![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![Publish Open Access Finland]({"type":"image" , "src" : "/sda/110396/JournalAd-OA-Agreements.gif"})
![Annals of medicine, now fully Open Access!]({"type":"image" , "src" : "/sda/110649/IANN-Dermatology.gif"})
"The cost of liver function tests for terbinafine: an unnecessary expense." Journal of Dermatological Treatment, ahead-of-print(ahead-of-print), p. 1
Disclosure statement
Dr. Fleischer is a consultant for Boerhringer-Ingelheim, Incyte, Qurient, SCM Lifescience and Syneos. He is an investigator for Galderma and Trevi. He has no other potential conflicts including Honoraria, Speakers bureau, Stock ownership or options, Expert testimony, Grants, Patents filed, received, pending, or in preparation, Royalties, or Donation of medical equipment. Dr. Housholder is a sub-investigator for Leo Pharma, Acetelion, and US World Meds.